Elaine Waller, Pharm.D.

Executive Vice President, Regulatory Affairs and Clinical Development Operations

Elaine Waller, Pharm.D., joined Seattle Genetics in September 2008, bringing more than 20 years of experience in regulatory affairs and clinical research. Prior to joining Seattle Genetics, Dr. Waller was with Sonus Pharmaceuticals, where she served as Senior Vice President, Regulatory Affairs/Quality Assurance and Clinical Research until its merger with OncoGenex Pharmaceuticals in August 2008. Before that, she was Chief Operating Officer at Radiant Research, a clinical site management organization. Dr. Waller's previous experience includes senior positions in regulatory affairs and clinical research at Hoechst Marion Roussel and Marion Merrell Dow, predecessor companies to sanofi-aventis. She began her career in academia at the University of Texas at Austin where she held teaching positions in both graduate and undergraduate pharmacy education and was Assistant Director of Clinical Research at the Drug Dynamics Institute. Dr. Waller received a B.S. in Pharmacy and a Doctor of Pharmacy from the University of Missouri-Kansas City and an M.B.A. from Rockhurst College.

You are now leaving Seattle Genetics' site. Seattle Genetics does not necessarily endorse the organization associated with this link and takes no responsibility for the content contained therein. This resource link is for informational purposes only. Do you want to continue to the external site and leave SeattleGenetics.com?

No, return to SeattleGenetics.com

Yes, leave SeattleGenetics.com